Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions
Vulvar Lichen Sclerosus
Interventions
DRUG

Injection of autologous fatty tissue associated with autologous platelet-rich plasma.

Patients will receive 2 separate infiltrations for three months by intra and subdermal injection of autologous fatty tissue (20cc) associated with autologous platelet-rich plasma (4cc) in each half vulvar.

DRUG

Corticosteroids (clobetasol 0.05%)

Patients will receive a maintenance treatment of topical therapy with corticosteroids (clobetasol 0.05%) that will be administered by usual clinical practice.

Trial Locations (1)

Unknown

Hospital Universitario y Politécnico La Fe, Valencia

All Listed Sponsors
lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT03961126 - Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma. | Biotech Hunter | Biotech Hunter